Antibiotics Market Analysis and Forecast to 2031: By Class (Beta Lactam & Beta Lactamase, Quinolones, Macrolides, and Others), Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic and Narrow-spectrum Antibiotic), Route of Administration (Oral, Intravenous, and Others), and Region

Antibiotics are a type of medication that are used to treat infections caused by bacteria. They work by killing the bacteria or preventing them from multiplying. There are many different types of antibiotics, and they are usually classified according to their mechanism of action. Some common examples include penicillin, cephalosporins, and macrolides. Antibiotics are usually taken orally in the form of pills, but they can also be given intravenously. The length of treatment depends on the type of infection, but it typically lasts for 7-10 days.

Key Trends

The development of new antibiotics has lagged behind the rise in drug-resistant bacteria, leading to a growing public health threat. In response, governments, academia, and industry are working to revive the antibiotic pipeline through a variety of initiatives.

One key trend is the use of precision medicine to develop more targeted antibiotics. This approach aims to understand the specific genetic makeup of a patient’s infection and then design a tailored treatment. This could help to reduce the chances of resistance developing and also increase the effectiveness of the antibiotic.

Another trend is the use of artificial intelligence (AI) to screen large numbers of compounds for their potential as antibiotics. This approach has the potential to speed up the process of discovering new drugs and help to find novel treatments for resistant infections.

These are drugs that are reserved for use only when all other options have failed. This is because the more they are used, the greater the chances of resistance developing.

Finally, there is a growing recognition of the need to preserve existing antibiotics and use them more wisely. This includes measures such as reducing the use of antibiotics in agriculture and promoting the responsible use of antibiotics in human medicine.

Key Drivers

The key drivers of the antibiotics market are the rising incidence of infectious diseases, the growing awareness of the importance of timely treatment of infections, and the availability of new and effective antibiotics.

The rising incidence of infectious diseases is driven by the increasing global population, the increased international travel, and the spread of antibiotic-resistant bacteria.

The growing awareness of the importance of timely treatment of infections is driven by the increasing number of media reports of serious infections, such as MRSA, that can be fatal if not treated promptly.

The availability of new and effective antibiotics is driven by the development of new antibiotics by pharmaceutical companies and the increased use of antibiotics in animal husbandry.

Restraints & Challenges

The key restraints and challenges in the antibiotics market are the increasing resistance of bacteria to antibiotics and the lack of new antibiotics to treat these resistant bacteria.

The number of bacteria that are resistant to antibiotics is increasing, and the number of new antibiotics to treat these resistant bacteria is decreasing. This is a major challenge for the antibiotics market.

Market Segments

The Antibiotics Market is segmented by class, drug origin, spectrum of activity, route of administration. Based on class, the market is classified into beta lactam & beta lactamase inhibitors, quinolones, macrolides, and others. By drug origin, it is segmented into natural, semisynthetic and synthetic. Based on the spectrum of activity, the market is bifurcated into broad-spectrum antibiotic and narrow-spectrum antibiotic. By route of administration, it is segmented into oral, intravenous, and others. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The Antibiotics Market includes players such as Abbott Laboratories, Allergan Plc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co. Inc., Mylan N.V., Novartis International AG (Sandoz), Pfizer Inc., Sanofi and Teva Pharmaceutical Industries Ltd.

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Antibiotics Market Outlook
3.1. Antibiotics Market Segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Antibiotics Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Antibiotics Market
4.3. Economic Impact Analysis

Chapter 5. Antibiotics Market by Class
5.1. Market Overview
5.2. Beta Lactam & Beta Lactamase Inhibitors
5.2.1. Market Size and Forecast, 2021-2031 ($Million)
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Quinolone
5.3.1. Market Size and Forecast, 2021-2031 ($Million)
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.4. Macrolide
5.4.1. Market Size and Forecast, 2021-2031 ($Million)
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.5. Others
5.5.1. Market Size and Forecast, 2021-2031 ($Million)
5.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Antibiotics Market by Drug Origin
6.1. Market Overview
6.2. Natural
6.2.1. Market Size and Forecast, 2021-2031 ($Million)
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Semisynthetic
6.3.1. Market Size and Forecast, 2021-2031 ($Million)
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Synthetic
6.4.1. Market Size and Forecast, 2021-2031 ($Million)
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Antibiotics Market by Spectrum Of Activity
7.1. Market Overview
7.2. Broad-spectrum Antibiotic
7.2.1. Market Size and Forecast, 2021-2031 ($Million)
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Narrow-spectrum Antibiotic
7.3.1. Market Size and Forecast, 2021-2031 ($Million)
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Antibiotics Market by Route Of Administration
8.1. Market Overview
8.2. Oral
8.2.1. Market Size and Forecast, 2021-2031 ($Million)
8.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
8.3. Intravenous
8.3.1. Market Size and Forecast, 2021-2031 ($Million)
8.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
8.4. Others
8.4.1. Market Size and Forecast, 2021-2031 ($Million)
8.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 9. Antibiotics Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. North America Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.2.3. North America Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.2.4. North America Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.2.5. North America Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.2.6. North America Antibiotics Market Size and Forecast by Country, 2021-2031, ($Million)
9.2.7. The U.S.
9.2.7.1. The U.S. Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.2.7.2. The U.S. Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.2.7.3. The U.S. Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.2.7.4. The U.S. Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.2.8. Canada
9.2.8.1. Canada Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.2.8.2. Canada Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.2.8.3. Canada Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.2.8.4. Canada Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.2.9. Mexico
9.2.9.1. Mexico Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.2.9.2. Mexico Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.2.9.3. Mexico Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.2.9.4. Mexico Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Europe Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.3.3. Europe Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.3.4. Europe Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.3.5. Europe Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.3.6. Europe Antibiotics Market Size and Forecast by Country, 2021-2031, ($Million)
9.3.7. Germany
9.3.7.1. Germany Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.3.7.2. Germany Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.3.7.3. Germany Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.3.7.4. Germany Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.3.8. France
9.3.8.1. France Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.3.8.2. France Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.3.8.3. France Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.3.8.4. France Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.3.9. U.K.
9.3.9.1. U.K. Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.3.9.2. U.K. Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.3.9.3. U.K. Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.3.9.4. U.K. Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.3.10. Spain
9.3.10.1. Spain Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.3.10.2. Spain Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.3.10.3. Spain Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.3.10.4. Spain Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.3.11. Italy
9.3.11.1. Italy Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.3.11.2. Italy Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.3.11.3. Italy Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.3.11.4. Italy Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.3.12. Rest of Europe
9.3.12.1. Rest of Europe Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.3.12.2. Rest of Europe Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.3.12.3. Rest of Europe Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.3.12.4. Rest of Europe Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Asia-Pacific Antibiotics Market Size and Forecast by Country, 2021-2031, ($Million)
9.4.3. Asia-Pacific Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.4.4. Asia-Pacific Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.4.5. Asia-Pacific Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.4.6. Asia-Pacific Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.4.7. China
9.4.7.1. China Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.4.7.2. China Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.4.7.3. China Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.4.7.4. China Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.4.8. India
9.4.8.1. India Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.4.8.2. India Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.4.8.3. India Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.4.8.4. India Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.4.9. Japan
9.4.9.1. Japan Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.4.9.2. Japan Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.4.9.3. Japan Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.4.9.4. Japan Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.4.10. South Korea
9.4.10.1. South Korea Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.4.10.2. South Korea Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.4.10.3. South Korea Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.4.10.4. South Korea Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.4.11. Rest of APAC
9.4.11.1. Rest of APAC Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.4.11.2. Rest of APAC Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.4.11.3. Rest of APAC Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.4.11.4. Rest of APAC Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.5. Rest of the World
9.5.1. Key Market Trends and Opportunities
9.5.2. Rest of the World Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.5.3. Rest of the World Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.5.4. Rest of the World Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.5.5. Rest of the World Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.5.6. Rest of the World Antibiotics Market Size and Forecast by Country, 2021-2031, ($Million)
9.5.7. Latin America
9.5.7.1. Latin America Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.5.7.2. Latin America Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.5.7.3. Latin America Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.5.7.4. Latin America Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.5.8. Middle East
9.5.8.1. Middle East Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.5.8.2. Middle East Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.5.8.3. Middle East Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.5.8.4. Middle East Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)
9.5.9. Africa
9.5.9.1. Africa Antibiotics Market Size and Forecast by Class, 2021-2031, ($Million)
9.5.9.2. Africa Antibiotics Market Size and Forecast by Drug Origin, 2021-2031, ($Million)
9.5.9.3. Africa Antibiotics Market Size and Forecast by Spectrum Of Activity, 2021-2031, ($Million)
9.5.9.4. Africa Antibiotics Market Size and Forecast by Route Of Administration, 2021-2031, ($Million)

Chapter 10. Competitive Landscape
10.1. Market Overview
10.2. Market Share Analysis/Key Player Positioning
10.3. Developmental Strategy Benchmarking
10.3.1. New Product Development
10.3.2. Product Launches
10.3.3. Business Expansions
10.3.4. Partnerships, Joint Ventures, and Collaborations
10.3.5. Mergers and Acquisitions

Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Product Offerings
11.1.4. Key Strategic Initiatives
11.1.5. SWOT Analysis
11.2. Allergan Plc.
11.2.1. Company Snapshot
11.2.2. Financial Performance
11.2.3. Product offerings
11.2.4. Key Strategic Initiatives
11.2.5. SWOT Analysis
11.3. F. Hoffmann-La Roche Ltd.
11.3.1. Company Snapshot
11.3.2. Financial Performance
11.3.3. Product offerings
11.3.4. Key Strategic Initiatives
11.3.5. SWOT Analysis
11.4. GlaxoSmithKline plc
11.4.1. Company Snapshot
11.4.2. Financial Performance
11.4.3. Product offerings
11.4.4. Key Strategic Initiatives
11.4.5. SWOT Analysis
11.5. Merck & Co. Inc.
11.5.1. Company Snapshot
11.5.2. Financial Performance
11.5.3. Product offerings
11.5.4. Key Strategic Initiatives
11.5.5. SWOT Analysis
11.6. Mylan N.V.
11.6.1. Company Snapshot
11.6.2. Financial Performance
11.6.3. Product offerings
11.6.4. Key Strategic Initiatives
11.6.5. SWOT Analysis
11.7. Novartis International AG (Sandoz)
11.7.1. Company Snapshot
11.7.2. Financial Performance
11.7.3. Product offerings
11.7.4. Key Strategic Initiatives
11.7.5. SWOT Analysis
11.8. Pfizer Inc.
11.8.1. Company Snapshot
11.8.2. Financial Performance
11.8.3. Product offerings
11.8.4. Key Strategic Initiatives
11.8.5. SWOT Analysis
11.9. Sanofi
11.9.1. Company Snapshot
11.9.2. Financial Performance
11.9.3. Product offerings
11.9.4. Key Strategic Initiatives
11.9.5. SWOT Analysis
11.10. Teva Pharmaceutical Industries Ltd.
11.10.1. Company Snapshot
11.10.2. Financial Performance
11.10.3. Product offerings
11.10.4. Key Strategic Initiatives
11.10.5. SWOT Analysis

*The list of company is subject to change during the final compilation of the report

 

 

 

 

 

 

Key Players
  • Abbott Laboratories
  • Allergan Plc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis International AG (Sandoz)
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
Market Segments

By Class

  • Beta Lactam & Beta Lactamase Inhibitors
  • Quinolone
  • Macrolide
  • Others

By Drug Origin

  • Natural
  • Semisynthetic
  • Synthetic

By Spectrum Of Activity

  • Broad-spectrum Antibiotic
  • Narrow-spectrum Antibiotic

By Route Of Administration

  • Oral
  • Intravenous
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Periodontal disease is also called as gum disease.…
The global Helicobacter Pylori Testing Market was valued…
Lupus Nephritis is an autoimmune kidney disease caused…
There are a variety of ophthalmic drugs available…
Gout is a form of inflammatory arthritis marked…
Restless Legs Syndrome (RLS) is a neurological disorder…
Dental laboratories are businesses that provide dental products…
Lassa fever is an acute viral hemorrhagic illness…
Genomics is the study of genes and their…
An active pharmaceutical ingredient (API) is a component…